State Street’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.36M | Buy |
856,186
+63,175
| +8% | +$395K | ﹤0.01% | 2913 |
|
|
2025
Q1 | $4.65M | Sell |
793,011
-8,812
| -1% | -$51.6K | ﹤0.01% | 2906 |
|
|
2024
Q4 | $6.59M | Buy |
801,823
+47,020
| +6% | +$387K | ﹤0.01% | 2836 |
|
|
2024
Q3 | $6.73M | Buy |
754,803
+26,841
| +4% | +$239K | ﹤0.01% | 2817 |
|
|
2024
Q2 | $5.5M | Buy |
727,962
+158,158
| +28% | +$1.2M | ﹤0.01% | 2888 |
|
|
2024
Q1 | $4.47M | Buy |
569,804
+63,542
| +13% | +$499K | ﹤0.01% | 2972 |
|
|
2023
Q4 | $4.49M | Buy |
506,262
+48,902
| +11% | +$433K | ﹤0.01% | 2998 |
|
|
2023
Q3 | $4.1M | Buy |
457,360
+4,093
| +0.9% | +$36.7K | ﹤0.01% | 3019 |
|
|
2023
Q2 | $5.6M | Buy |
453,267
+104,712
| +30% | +$1.29M | ﹤0.01% | 2941 |
|
|
2023
Q1 | $3.23M | Buy |
348,555
+37,865
| +12% | +$351K | ﹤0.01% | 3150 |
|
|
2022
Q4 | $3.26M | Buy |
310,690
+12,252
| +4% | +$129K | ﹤0.01% | 3226 |
|
|
2022
Q3 | $5.41M | Buy |
298,438
+41,692
| +16% | +$756K | ﹤0.01% | 3020 |
|
|
2022
Q2 | $3.64M | Buy |
256,746
+171,764
| +202% | +$2.43M | ﹤0.01% | 3252 |
|
|
2022
Q1 | $1.87M | Buy |
84,982
+37,797
| +80% | +$832K | ﹤0.01% | 3596 |
|
|
2021
Q4 | $801K | Buy |
+47,185
| New | +$801K | ﹤0.01% | 3865 |
|